Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants, study finds

by Perelman School of Medicine at the University of PennsylvaniaGraphical abstract. Credit:Immunity(2024). DOI: 10.1016/j.immuni.2024.02.017A new study from the Perelman School of Med

Updated on: March 19,2024 13

Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants, study finds

by Perelman School of Medicine at the University of PennsylvaniaGraphical abstract. Credit:Immunity(2024). DOI: 10.1016/j.immuni.2024.02.017A new study from the Perelman School of Med

Updated on:March 19,2024 13

T cells recognize recent SARS-CoV-2 variants

by NIH/National Institute of Allergy and Infectious DiseasesColorized scanning electron micrograph of a dying cell (blue) heavily infected with SARS-CoV-2 (yellow), the virus that causes COVID-19

Updated on: May 08,2024 5

T cells recognize recent SARS-CoV-2 variants

by NIH/National Institute of Allergy and Infectious DiseasesColorized scanning electron micrograph of a dying cell (blue) heavily infected with SARS-CoV-2 (yellow), the virus that causes COVID-19

Updated on:May 08,2024 5

Review discusses metabolic reprogramming of T cells

by Cactus CommunicationsT cell immunotherapy can be optimized by understanding the metabolism of T cells. This review article summarizes the intricacies of effector and memory T cell metabolic reprogr

Updated on: March 07,2024 12

Review discusses metabolic reprogramming of T cells

by Cactus CommunicationsT cell immunotherapy can be optimized by understanding the metabolism of T cells. This review article summarizes the intricacies of effector and memory T cell metabolic reprogr

Updated on:March 07,2024 12

This gross mixture has big benefits for the study of bacteria

byUniversity of MichiganDetermining the bottleneck of infection forP. mirabilisduring UTI. (A–C) CBA/J mice were transurethrally inoculated with 107CFU. The inoculum contained

Updated on: January 25,2024 17

This gross mixture has big benefits for the study of bacteria

byUniversity of MichiganDetermining the bottleneck of infection forP. mirabilisduring UTI. (A–C) CBA/J mice were transurethrally inoculated with 107CFU. The inoculum contained

Updated on:January 25,2024 17

Phosphorylation of Regnase-1 lets IL-17 run amok

by Osaka UniversityCredit: CC0 Public DomainWhen considering the role of the key immune molecule interleukin (IL)-17, the phrase "too much of a good thing" springs to mind. Because unli

Updated on: April 22,2024 14

Phosphorylation of Regnase-1 lets IL-17 run amok

by Osaka UniversityCredit: CC0 Public DomainWhen considering the role of the key immune molecule interleukin (IL)-17, the phrase "too much of a good thing" springs to mind. Because unli

Updated on:April 22,2024 14

Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses

by University of Alabama at BirminghamCredit: University of Alabama at BirminghamPreclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show positive resul

Updated on: April 10,2024 10

Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses

by University of Alabama at BirminghamCredit: University of Alabama at BirminghamPreclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show positive resul

Updated on:April 10,2024 10

Preventing cell death as novel therapeutic strategy for rheumatoid arthritis

by VIB (the Flanders Institute for Biotechnology)Credit: CC0 Public DomainA collaborative study has identified a new molecular mechanism causing rheumatoid arthritis. The researchers found that d

Updated on: March 30,2024 19

Preventing cell death as novel therapeutic strategy for rheumatoid arthritis

by VIB (the Flanders Institute for Biotechnology)Credit: CC0 Public DomainA collaborative study has identified a new molecular mechanism causing rheumatoid arthritis. The researchers found that d

Updated on:March 30,2024 19

Study finds combination therapy does little to slow spine damage in radiographic axial spondyloarthritis patients

by American College of RheumatologyCumulative probability plot of mSASSS progression over 108 weeks of treatment. Credit: COmparison of the Effect of Treatment with NSAIDs Added to Anti-TNF Thera

Updated on: May 13,2024 8

Study finds combination therapy does little to slow spine damage in radiographic axial spondyloarthritis patients

by American College of RheumatologyCumulative probability plot of mSASSS progression over 108 weeks of treatment. Credit: COmparison of the Effect of Treatment with NSAIDs Added to Anti-TNF Thera

Updated on:May 13,2024 8

Unveiling the New Defense Against COVID-19! Recent Research Identifies the Immune Evasion Mechanism of SARS-CoV-2 and Its Variants

Updated on: June 05,2024 0

Unveiling the New Defense Against COVID-19! Recent Research Identifies the Immune Evasion Mechanism of SARS-CoV-2 and Its Variants

Updated on:June 05,2024 0

Causes of osteoarthritis mapped in new biobank

by Sanna Trygg,Lund University"What are the fundamental mechanical causes of osteoarthritis? And how can we slow or reverse its progression?" These are the questions asked by professor

Updated on: March 30,2024 19

Causes of osteoarthritis mapped in new biobank

by Sanna Trygg,Lund University"What are the fundamental mechanical causes of osteoarthritis? And how can we slow or reverse its progression?" These are the questions asked by professor

Updated on:March 30,2024 19

SRC-3 is a novel regulator of human immune T regulatory cells

by Baylor College of MedicineSuzanne Judd, Ph.D., an epidemiologist at UAB, explains what will lead to herd immunity and why it is important to remain vigilant in reducing the spread of COVID-19.

Updated on: April 22,2024 18

SRC-3 is a novel regulator of human immune T regulatory cells

by Baylor College of MedicineSuzanne Judd, Ph.D., an epidemiologist at UAB, explains what will lead to herd immunity and why it is important to remain vigilant in reducing the spread of COVID-19.

Updated on:April 22,2024 18

CAR T cell therapy could reach beyond cancer

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainEngineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can

Updated on: April 09,2024 18

CAR T cell therapy could reach beyond cancer

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainEngineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can

Updated on:April 09,2024 18